A 68-Year-Old Man With Mantle Cell Lymphoma

EP. 1: Case Assessment: 68-Year-Old Patient With MCL

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 2: Diagnosing MCL and Making Informed Treatment Decisions

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 3: Initiating Therapy for Mantle Cell Lymphoma

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 4: Relapsed Mantle Cell Lymphoma Treatment Landscape

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 5: Administration of BTK Inhibitors for Mantle Cell Lymphoma

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 6: BTK Inhibitor Toxicities in Mantle Cell Lymphoma

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 7: BTK Inhibitors in MCL: Long-Term Safety & Efficacy Data

ByJonathon B. Cohen, MD, MS
May 18th 2020

EP. 8: Next Steps in Relapsed/Refractory Mantle Cell Lymphoma

ByJonathon B. Cohen, MD, MS
May 18th 2020